pelvic floor dysfunction
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Female users registered to use the Dayue Home Pelvic Floor Muscle Treatment Device from December 2022 to November 2024; 2.Age >= 18 years old; 3.Users who have completed 15 sessions of pelvic floor muscle strength assessment using the pelvic floor muscle therapy device for the first time, with a 90 day extension from the expected date (intervention period);
Exclusion criteria
Exclusion criteria: 1.Non active users: No treatment records within 12 months; 2.Refusal to participate in research; 3.Asexual life history; 4.Spasmodic paralysis, limb joint contracture deformity; 5.Patients using implantable metal or electronic devices (such as pacemakers); 6.Individuals who have undergone pelvic floor surgery within the first six months prior to registering for the use of the Dayue Pelvic Floor Muscle Therapy Device, as well as those with serious illnesses or frailty (such as those with malignant tumors, severe liver, liver, and kidney failure, spasticity after a cerebrovascular accident, heart disease patients, etc.); 7.Users with certain neurological disorders (such as complete denervation of pelvic floor muscles, dementia, abscess), drug-induced neurological disorders, severe cognitive impairment, unclear consciousness, and inability to actively cooperate with treatment;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Patient General Health Improvement Questionnaire (PGI-I); | — |
Secondary
| Measure | Time frame |
|---|---|
| Pelvic floor electromyography assessment;Summary score of the International Urinary Incontinence Advisory Committee Urinary Incontinence Questionnaire (ICIQ-UI-SF);Vaginal laxity questionnaire (VLQ); | — |
Countries
China
Contacts
Peking Union Medical College Hospital, Chinese Academy of Medical Sciences